Related Experiment Videos
RP 54745, a potential antirheumatic compound. I. Inhibitor of macrophage stimulation and interleukin-1 production
F Folliard1, A Bousseau, B Terlain
1Rhône-Poulenc Rorer, Centre de Recherche de Vitry-Alfortville, Vitry sur Seine, France.
Abstract:
RP 54745 is an amino-dithiole-one compound found to be active at micromolar concentration on the metabolism of stimulated macrophages, for example, the hexose monophosphate pathway (HMP) and the exocytosis of lysosomal enzymes. LPS-induced interleukin-1 (IL-1) production by murine peritoneal macrophages was also diminished by this compound in vitro as well as in vivo. This effect was confirmed at the mRNA level; at the concentration of 3 x 10(-6) M, the IL-1 alpha and beta mRNA signals were inhibited, whereas the TNF alpha mRNA signal was only slightly lessened. These observations were confirmed in vivo, with a dose of RP 54745 of 25 mg kg-1. These results led us to consider that RP 54745 might influence certain cells and cytokines implicated in the regulation of the immune system, the disfunctioning of which can lead to inflammatory disorders or autoimmune pathologies.
Insights
RP 54745, an amino-dithiole-one, modulates macrophage metabolism and reduces interleukin-1 (IL-1) production. This compound shows potential for regulating immune responses and addressing inflammatory and autoimmune diseases.
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Macrophages play a critical role in immune responses.
- Dysregulation of macrophage function is implicated in inflammatory and autoimmune diseases.
- Interleukin-1 (IL-1) is a key pro-inflammatory cytokine.
Purpose of the Study:
- To investigate the effects of RP 54745 on macrophage metabolism and cytokine production.
- To evaluate the potential of RP 54745 as an immunomodulatory agent.
Main Methods:
- Assessing the impact of RP 54745 on macrophage metabolism, including the hexose monophosphate pathway (HMP) and lysosomal enzyme exocytosis.
- Measuring lipopolysaccharide (LPS)-induced interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) production in murine peritoneal macrophages in vitro and in vivo.
- Analyzing mRNA levels of IL-1 alpha, IL-1 beta, and TNF-alpha.
Main Results:
- RP 54745 demonstrated activity at micromolar concentrations on stimulated macrophage metabolism.
- The compound inhibited LPS-induced IL-1 production in macrophages both in vitro and in vivo.
- RP 54745 significantly reduced IL-1 alpha and beta mRNA levels, with a minor effect on TNF-alpha mRNA.
Conclusions:
- RP 54745 exhibits immunomodulatory properties by affecting macrophage metabolism and IL-1 production.
- The compound's ability to influence key immune regulators suggests therapeutic potential for inflammatory and autoimmune conditions.
- Further research into RP 54745 is warranted to explore its role in immune system regulation.